Dendreon Corporation (DNDN)

Company Overview
Dendreon Corporation (unless the context suggests otherwise, “Dendreon”, the “Company”, “we”, “us”, or “our”), a Delaware corporation originally formed in 1992 as Activated Cell Therapy, Inc., is a biotechnology company focused on the discovery, development and commercialization of novel therapeutics that harness the immune system to fight cancer. Our goal is to develop innovative cancer treatments that significantly improve cancer treatment options for patients. Our product portfolio includes active cellular immunotherapy, monoclonal antibody and small molecule product candidates to treat a wide range of cancers. Our most advanc...
read more

COMPANY INFO

To see the headquarters in Google Street View &trade, drag this yellow guy: over to the red pointer:

Contact Information:

Business Address: 3005 First Avenue, Seattle, WA 98121, United States
Mailing Address: -
Phone: 206-256-4545
Fax: 206-256-0571
Website: http//www.dendreon.com

Company Details:

Symbol: DNDN
SIC: 2834
State location: WA
Sector: -
State of Inc: DE
Employees: 484
Type: -

Key executives:

Name Age Position
Greg Cox 2021 Principal Accounting Officer
Gregory T. Schiffman MBA, CPA 62 Chief Financial Officer, Sr. VP and Treasurer
Linda Staley 2021 VP of Information Technology
Mitchell H. Gold M.D. 53 Chief Exec. Officer, Pres
Richard F. Hamm Jr. 61 Sr. VP of Corp. Devel., Sec. and Gen. Counsel